

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein maturation by protein folding (GO:0022417) | 8.61112236 |
| 2 | establishment of viral latency (GO:0019043) | 7.44389887 |
| 3 | establishment of integrated proviral latency (GO:0075713) | 7.27735200 |
| 4 | extracellular fibril organization (GO:0043206) | 6.52846280 |
| 5 | fibril organization (GO:0097435) | 5.45885010 |
| 6 | * detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 5.36579562 |
| 7 | positive regulation of actin filament depolymerization (GO:0030836) | 5.19825551 |
| 8 | response to gravity (GO:0009629) | 5.14927549 |
| 9 | nuclear envelope reassembly (GO:0031468) | 5.07398834 |
| 10 | mitotic nuclear envelope reassembly (GO:0007084) | 5.07398834 |
| 11 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 5.06505148 |
| 12 | endothelial tube morphogenesis (GO:0061154) | 4.75620068 |
| 13 | morphogenesis of an endothelium (GO:0003159) | 4.75620068 |
| 14 | DNA unwinding involved in DNA replication (GO:0006268) | 4.68148103 |
| 15 | regulation of metalloenzyme activity (GO:0048552) | 4.46290607 |
| 16 | * detection of chemical stimulus involved in sensory perception of taste (GO:0050912) | 4.34396612 |
| 17 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.18943323 |
| 18 | muscle cell migration (GO:0014812) | 4.16718706 |
| 19 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.13139873 |
| 20 | negative regulation of glycoprotein metabolic process (GO:1903019) | 4.11453775 |
| 21 | proteasome assembly (GO:0043248) | 4.06881337 |
| 22 | positive regulation of pseudopodium assembly (GO:0031274) | 4.05856031 |
| 23 | type B pancreatic cell proliferation (GO:0044342) | 3.96637677 |
| 24 | sequestering of actin monomers (GO:0042989) | 3.95350770 |
| 25 | response to interferon-beta (GO:0035456) | 3.93490367 |
| 26 | COPI coating of Golgi vesicle (GO:0048205) | 3.93025540 |
| 27 | Golgi transport vesicle coating (GO:0048200) | 3.93025540 |
| 28 | galactose catabolic process (GO:0019388) | 3.91087768 |
| 29 | actin filament depolymerization (GO:0030042) | 3.87667115 |
| 30 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.80568465 |
| 31 | barbed-end actin filament capping (GO:0051016) | 3.67236381 |
| 32 | regulation of pseudopodium assembly (GO:0031272) | 3.63086422 |
| 33 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.57782098 |
| 34 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 3.54114902 |
| 35 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.51420510 |
| 36 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 3.49424372 |
| 37 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 3.44738820 |
| 38 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 3.44738820 |
| 39 | protein retention in ER lumen (GO:0006621) | 3.44095218 |
| 40 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.43767622 |
| 41 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.41322623 |
| 42 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.40789141 |
| 43 | negative regulation of ligase activity (GO:0051352) | 3.39847764 |
| 44 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.39847764 |
| 45 | nucleoside transmembrane transport (GO:1901642) | 3.39160656 |
| 46 | cellular copper ion homeostasis (GO:0006878) | 3.37546365 |
| 47 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.31218847 |
| 48 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.31218847 |
| 49 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.29956153 |
| 50 | lipopolysaccharide biosynthetic process (GO:0009103) | 3.29830609 |
| 51 | heterochromatin organization (GO:0070828) | 3.26577180 |
| 52 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.23120816 |
| 53 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.23120816 |
| 54 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.23120816 |
| 55 | membrane raft organization (GO:0031579) | 3.20536072 |
| 56 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.20257358 |
| 57 | pattern specification involved in kidney development (GO:0061004) | 3.17948011 |
| 58 | galactose metabolic process (GO:0006012) | 3.16772506 |
| 59 | positive regulation of protein complex disassembly (GO:0043243) | 3.16272312 |
| 60 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.13357593 |
| 61 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.13357593 |
| 62 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.12895799 |
| 63 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.07772738 |
| 64 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.06578868 |
| 65 | cellular response to zinc ion (GO:0071294) | 3.06183385 |
| 66 | cortical actin cytoskeleton organization (GO:0030866) | 3.03000331 |
| 67 | fibrinolysis (GO:0042730) | 2.97569677 |
| 68 | pyrimidine nucleoside salvage (GO:0043097) | 2.96525850 |
| 69 | pyrimidine-containing compound salvage (GO:0008655) | 2.96525850 |
| 70 | regulation of mitochondrial translation (GO:0070129) | 2.94232056 |
| 71 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.94013150 |
| 72 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.92279204 |
| 73 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.89616700 |
| 74 | endosome to pigment granule transport (GO:0043485) | 2.88726088 |
| 75 | endosome to melanosome transport (GO:0035646) | 2.88726088 |
| 76 | termination of RNA polymerase III transcription (GO:0006386) | 2.87301923 |
| 77 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.87301923 |
| 78 | protein complex biogenesis (GO:0070271) | 2.85303675 |
| 79 | negative regulation of mitochondrion organization (GO:0010823) | 2.84213002 |
| 80 | GDP-mannose metabolic process (GO:0019673) | 2.80706638 |
| 81 | glycolytic process (GO:0006096) | 2.80508314 |
| 82 | response to copper ion (GO:0046688) | 2.76403921 |
| 83 | base-excision repair (GO:0006284) | 2.75363369 |
| 84 | protein deneddylation (GO:0000338) | 2.74919626 |
| 85 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.74296455 |
| 86 | copper ion homeostasis (GO:0055070) | 2.74169377 |
| 87 | cullin deneddylation (GO:0010388) | 2.73615127 |
| 88 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.73012418 |
| 89 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.72595128 |
| 90 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.72535351 |
| 91 | chaperone-mediated protein transport (GO:0072321) | 2.72495862 |
| 92 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.71515166 |
| 93 | positive regulation of ligase activity (GO:0051351) | 2.71126114 |
| 94 | lipopolysaccharide metabolic process (GO:0008653) | 2.68859549 |
| 95 | DNA strand elongation (GO:0022616) | 2.68856438 |
| 96 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.67686580 |
| 97 | cortical cytoskeleton organization (GO:0030865) | 2.67395941 |
| 98 | AMP metabolic process (GO:0046033) | 2.65113407 |
| 99 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.63284604 |
| 100 | ATP synthesis coupled proton transport (GO:0015986) | 2.63284604 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.90717359 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.59612739 |
| 3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.58066622 |
| 4 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.11172205 |
| 5 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.96995329 |
| 6 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.88869103 |
| 7 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.80006670 |
| 8 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.60821279 |
| 9 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.59250709 |
| 10 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 2.49037453 |
| 11 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.47641122 |
| 12 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 2.45168609 |
| 13 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.43519318 |
| 14 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.40728221 |
| 15 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.36671526 |
| 16 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.36154598 |
| 17 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.26883403 |
| 18 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.24513880 |
| 19 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.16825202 |
| 20 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.10307113 |
| 21 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.10180285 |
| 22 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.09167570 |
| 23 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.01064395 |
| 24 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.99418554 |
| 25 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.98122026 |
| 26 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.88742218 |
| 27 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.84252144 |
| 28 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.83018809 |
| 29 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.82914366 |
| 30 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.82839012 |
| 31 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.80594678 |
| 32 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.75769501 |
| 33 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.75742164 |
| 34 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.73665429 |
| 35 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.72855286 |
| 36 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.69975783 |
| 37 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.68470848 |
| 38 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.65601426 |
| 39 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.62795208 |
| 40 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.60597211 |
| 41 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.56829127 |
| 42 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.54886944 |
| 43 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.51348641 |
| 44 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.50649994 |
| 45 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48708456 |
| 46 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.45124650 |
| 47 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.44647734 |
| 48 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.43319254 |
| 49 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.40529279 |
| 50 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.40223517 |
| 51 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.39937724 |
| 52 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.38389659 |
| 53 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.38113159 |
| 54 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.37586452 |
| 55 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.37406024 |
| 56 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.33419962 |
| 57 | ATF3_27146783_Chip-Seq_COLON_Human | 1.30160996 |
| 58 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.28729253 |
| 59 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.28559363 |
| 60 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.26346231 |
| 61 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.26038078 |
| 62 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.24100612 |
| 63 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.24100612 |
| 64 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21890264 |
| 65 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.18967389 |
| 66 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.18217975 |
| 67 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.17275870 |
| 68 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.16380096 |
| 69 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.16117472 |
| 70 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.15664176 |
| 71 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.15222482 |
| 72 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.15184134 |
| 73 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.14729816 |
| 74 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.13982961 |
| 75 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.13639496 |
| 76 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.13593881 |
| 77 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.12818382 |
| 78 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.11077331 |
| 79 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.10344418 |
| 80 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.09066050 |
| 81 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.08482383 |
| 82 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.08371925 |
| 83 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.07356678 |
| 84 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.07086855 |
| 85 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 1.06892338 |
| 86 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.05514799 |
| 87 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.05248444 |
| 88 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.05220777 |
| 89 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.03493978 |
| 90 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.03150801 |
| 91 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.02964760 |
| 92 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.02954209 |
| 93 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.02760195 |
| 94 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.01258148 |
| 95 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.99764630 |
| 96 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99388983 |
| 97 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98706940 |
| 98 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.98309862 |
| 99 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.97434422 |
| 100 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.96697881 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003123_paternal_imprinting | 4.55576705 |
| 2 | MP0003191_abnormal_cellular_cholesterol | 4.33940934 |
| 3 | MP0000751_myopathy | 3.60600650 |
| 4 | MP0010030_abnormal_orbit_morphology | 3.50047870 |
| 5 | MP0004510_myositis | 3.46024577 |
| 6 | MP0005257_abnormal_intraocular_pressure | 3.18993608 |
| 7 | MP0000750_abnormal_muscle_regeneration | 2.91873013 |
| 8 | MP0005165_increased_susceptibility_to | 2.91477690 |
| 9 | MP0003950_abnormal_plasma_membrane | 2.77302821 |
| 10 | MP0003075_altered_response_to | 2.69652550 |
| 11 | MP0002877_abnormal_melanocyte_morpholog | 2.66572537 |
| 12 | MP0004272_abnormal_basement_membrane | 2.63187005 |
| 13 | MP0000749_muscle_degeneration | 2.60523070 |
| 14 | MP0005058_abnormal_lysosome_morphology | 2.58100710 |
| 15 | MP0001542_abnormal_bone_strength | 2.57789053 |
| 16 | MP0002332_abnormal_exercise_endurance | 2.54837615 |
| 17 | MP0003566_abnormal_cell_adhesion | 2.38248564 |
| 18 | MP0003315_abnormal_perineum_morphology | 2.32559021 |
| 19 | MP0005330_cardiomyopathy | 2.10001781 |
| 20 | MP0009840_abnormal_foam_cell | 2.07732992 |
| 21 | MP0000343_altered_response_to | 2.02852971 |
| 22 | MP0006054_spinal_hemorrhage | 2.00847568 |
| 23 | MP0005367_renal/urinary_system_phenotyp | 1.91286585 |
| 24 | MP0000516_abnormal_urinary_system | 1.91286585 |
| 25 | MP0000858_altered_metastatic_potential | 1.84580840 |
| 26 | MP0001853_heart_inflammation | 1.75630311 |
| 27 | MP0003806_abnormal_nucleotide_metabolis | 1.72477739 |
| 28 | MP0003786_premature_aging | 1.69613697 |
| 29 | MP0003329_amyloid_beta_deposits | 1.62968445 |
| 30 | MP0005360_urolithiasis | 1.61295282 |
| 31 | MP0001299_abnormal_eye_distance/ | 1.59773984 |
| 32 | MP0003186_abnormal_redox_activity | 1.54504550 |
| 33 | MP0008260_abnormal_autophagy | 1.52698636 |
| 34 | MP0005670_abnormal_white_adipose | 1.50462708 |
| 35 | MP0008775_abnormal_heart_ventricle | 1.48610944 |
| 36 | MP0003436_decreased_susceptibility_to | 1.43576960 |
| 37 | MP0004147_increased_porphyrin_level | 1.41659016 |
| 38 | MP0005464_abnormal_platelet_physiology | 1.38666322 |
| 39 | MP0002653_abnormal_ependyma_morphology | 1.35365054 |
| 40 | MP0009780_abnormal_chondrocyte_physiolo | 1.34094582 |
| 41 | MP0008438_abnormal_cutaneous_collagen | 1.31618255 |
| 42 | MP0009697_abnormal_copulation | 1.29424107 |
| 43 | MP0002972_abnormal_cardiac_muscle | 1.23290117 |
| 44 | MP0005166_decreased_susceptibility_to | 1.22500890 |
| 45 | MP0009333_abnormal_splenocyte_physiolog | 1.22022444 |
| 46 | MP0001243_abnormal_dermal_layer | 1.20020842 |
| 47 | MP0006036_abnormal_mitochondrial_physio | 1.19676024 |
| 48 | MP0000647_abnormal_sebaceous_gland | 1.19249480 |
| 49 | MP0005451_abnormal_body_composition | 1.17062657 |
| 50 | MP0002060_abnormal_skin_morphology | 1.16355400 |
| 51 | MP0005083_abnormal_biliary_tract | 1.16145857 |
| 52 | MP0005197_abnormal_uvea_morphology | 1.14994886 |
| 53 | MP0002177_abnormal_outer_ear | 1.13947682 |
| 54 | MP0003656_abnormal_erythrocyte_physiolo | 1.12782422 |
| 55 | MP0008007_abnormal_cellular_replicative | 1.09786149 |
| 56 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.09085727 |
| 57 | MP0001346_abnormal_lacrimal_gland | 1.06796159 |
| 58 | MP0003718_maternal_effect | 1.06482462 |
| 59 | MP0002282_abnormal_trachea_morphology | 1.05240352 |
| 60 | MP0003279_aneurysm | 1.03106671 |
| 61 | MP0001533_abnormal_skeleton_physiology | 0.98109322 |
| 62 | MP0003638_abnormal_response/metabolism_ | 0.93029328 |
| 63 | MP0000358_abnormal_cell_content/ | 0.92995089 |
| 64 | MP0004957_abnormal_blastocyst_morpholog | 0.91502139 |
| 65 | MP0010368_abnormal_lymphatic_system | 0.89982190 |
| 66 | MP0002106_abnormal_muscle_physiology | 0.89702573 |
| 67 | MP0000747_muscle_weakness | 0.88734634 |
| 68 | MP0003077_abnormal_cell_cycle | 0.88569448 |
| 69 | MP0005164_abnormal_response_to | 0.86710500 |
| 70 | MP0001905_abnormal_dopamine_level | 0.84461399 |
| 71 | MP0000604_amyloidosis | 0.82968829 |
| 72 | MP0003693_abnormal_embryo_hatching | 0.79870588 |
| 73 | MP0005501_abnormal_skin_physiology | 0.79599121 |
| 74 | MP0002006_tumorigenesis | 0.77702364 |
| 75 | MP0002837_dystrophic_cardiac_calcinosis | 0.77575837 |
| 76 | MP0008932_abnormal_embryonic_tissue | 0.77247585 |
| 77 | MP0002148_abnormal_hypersensitivity_rea | 0.75015406 |
| 78 | MP0009764_decreased_sensitivity_to | 0.74209312 |
| 79 | MP0000762_abnormal_tongue_morphology | 0.72259972 |
| 80 | MP0008058_abnormal_DNA_repair | 0.72100580 |
| 81 | MP0005266_abnormal_metabolism | 0.69087617 |
| 82 | MP0002295_abnormal_pulmonary_circulatio | 0.68692138 |
| 83 | MP0002019_abnormal_tumor_incidence | 0.66838755 |
| 84 | MP0009053_abnormal_anal_canal | 0.66547121 |
| 85 | MP0005395_other_phenotype | 0.65930657 |
| 86 | MP0001216_abnormal_epidermal_layer | 0.64888368 |
| 87 | MP0005390_skeleton_phenotype | 0.62967672 |
| 88 | MP0000249_abnormal_blood_vessel | 0.62401408 |
| 89 | MP0008469_abnormal_protein_level | 0.61795586 |
| 90 | MP0002796_impaired_skin_barrier | 0.61228490 |
| 91 | MP0008875_abnormal_xenobiotic_pharmacok | 0.60766112 |
| 92 | MP0005023_abnormal_wound_healing | 0.60722067 |
| 93 | MP0000534_abnormal_ureter_morphology | 0.60596707 |
| 94 | MP0005084_abnormal_gallbladder_morpholo | 0.60183482 |
| 95 | MP0003091_abnormal_cell_migration | 0.56573660 |
| 96 | MP0010771_integument_phenotype | 0.56317098 |
| 97 | MP0006035_abnormal_mitochondrial_morpho | 0.56209498 |
| 98 | MP0009278_abnormal_bone_marrow | 0.55575449 |
| 99 | MP0003195_calcinosis | 0.55058807 |
| 100 | MP0003111_abnormal_nucleus_morphology | 0.53441762 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Amyloidosis (HP:0011034) | 5.68414882 |
| 2 | Glucose intolerance (HP:0000833) | 4.46363963 |
| 3 | Reduced subcutaneous adipose tissue (HP:0003758) | 4.27082515 |
| 4 | Adrenal hypoplasia (HP:0000835) | 4.03797920 |
| 5 | Hepatocellular necrosis (HP:0001404) | 3.90828351 |
| 6 | Delayed CNS myelination (HP:0002188) | 3.82439517 |
| 7 | Premature rupture of membranes (HP:0001788) | 3.66529915 |
| 8 | Mitochondrial inheritance (HP:0001427) | 3.53513574 |
| 9 | Hepatic necrosis (HP:0002605) | 3.49092618 |
| 10 | Upper limb muscle weakness (HP:0003484) | 3.44976070 |
| 11 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.36791997 |
| 12 | Osteolytic defects of the hand bones (HP:0009699) | 3.36791997 |
| 13 | Cholecystitis (HP:0001082) | 3.33767778 |
| 14 | Abnormal gallbladder physiology (HP:0012438) | 3.33767778 |
| 15 | Microglossia (HP:0000171) | 3.32550988 |
| 16 | Distal lower limb muscle weakness (HP:0009053) | 3.28703892 |
| 17 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.16200263 |
| 18 | Acute necrotizing encephalopathy (HP:0006965) | 3.15535590 |
| 19 | Vertebral compression fractures (HP:0002953) | 3.08974247 |
| 20 | Vascular calcification (HP:0004934) | 3.06199402 |
| 21 | Abnormal glucose tolerance (HP:0001952) | 3.00685542 |
| 22 | Insulin resistance (HP:0000855) | 2.99451263 |
| 23 | Increased serum pyruvate (HP:0003542) | 2.97367607 |
| 24 | Axonal loss (HP:0003447) | 2.91964709 |
| 25 | Entropion (HP:0000621) | 2.89253403 |
| 26 | Increased CSF lactate (HP:0002490) | 2.83759683 |
| 27 | Joint hemorrhage (HP:0005261) | 2.83568728 |
| 28 | Rough bone trabeculation (HP:0100670) | 2.83148029 |
| 29 | Short nail (HP:0001799) | 2.80630502 |
| 30 | Abnormality of glycolysis (HP:0004366) | 2.78985367 |
| 31 | Type I transferrin isoform profile (HP:0003642) | 2.78504049 |
| 32 | Reduced antithrombin III activity (HP:0001976) | 2.77352620 |
| 33 | Hand muscle atrophy (HP:0009130) | 2.75451208 |
| 34 | Limb-girdle muscle atrophy (HP:0003797) | 2.70214461 |
| 35 | Exercise intolerance (HP:0003546) | 2.66020221 |
| 36 | Cardiovascular calcification (HP:0011915) | 2.65968795 |
| 37 | Acute encephalopathy (HP:0006846) | 2.60232770 |
| 38 | Shoulder girdle muscle weakness (HP:0003547) | 2.57894960 |
| 39 | Flat capital femoral epiphysis (HP:0003370) | 2.57021031 |
| 40 | Renal Fanconi syndrome (HP:0001994) | 2.56404332 |
| 41 | Increased hepatocellular lipid droplets (HP:0006565) | 2.56315110 |
| 42 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.53156713 |
| 43 | Pelvic girdle muscle weakness (HP:0003749) | 2.52809730 |
| 44 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.51417577 |
| 45 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.51417577 |
| 46 | J-shaped sella turcica (HP:0002680) | 2.49849932 |
| 47 | Exertional dyspnea (HP:0002875) | 2.49840593 |
| 48 | Progressive macrocephaly (HP:0004481) | 2.48688525 |
| 49 | Late onset (HP:0003584) | 2.47772252 |
| 50 | Vacuolated lymphocytes (HP:0001922) | 2.47370818 |
| 51 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.44719708 |
| 52 | Hepatosplenomegaly (HP:0001433) | 2.43688507 |
| 53 | Sparse eyelashes (HP:0000653) | 2.43089308 |
| 54 | Distal lower limb amyotrophy (HP:0008944) | 2.41999399 |
| 55 | Prolonged neonatal jaundice (HP:0006579) | 2.38710033 |
| 56 | Increased intramyocellular lipid droplets (HP:0012240) | 2.37910221 |
| 57 | Bifid uvula (HP:0000193) | 2.36869992 |
| 58 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.35996097 |
| 59 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.35996097 |
| 60 | Abnormal protein glycosylation (HP:0012346) | 2.35996097 |
| 61 | Abnormal glycosylation (HP:0012345) | 2.35996097 |
| 62 | Secondary amenorrhea (HP:0000869) | 2.34543350 |
| 63 | Opisthotonus (HP:0002179) | 2.32519864 |
| 64 | Abnormality of the sella turcica (HP:0002679) | 2.29162442 |
| 65 | Distal upper limb amyotrophy (HP:0007149) | 2.23735935 |
| 66 | Upper limb amyotrophy (HP:0009129) | 2.23735935 |
| 67 | Atrophic scars (HP:0001075) | 2.20866204 |
| 68 | Short clavicles (HP:0000894) | 2.20182105 |
| 69 | Testicular atrophy (HP:0000029) | 2.20154601 |
| 70 | Difficulty climbing stairs (HP:0003551) | 2.19422233 |
| 71 | Increased connective tissue (HP:0009025) | 2.18370434 |
| 72 | Myocardial infarction (HP:0001658) | 2.17623666 |
| 73 | Congenital, generalized hypertrichosis (HP:0004540) | 2.14646216 |
| 74 | Emotional lability (HP:0000712) | 2.14618388 |
| 75 | Down-sloping shoulders (HP:0200021) | 2.13657464 |
| 76 | Fatigue (HP:0012378) | 2.13034803 |
| 77 | Increased serum lactate (HP:0002151) | 2.11992989 |
| 78 | Lactic acidosis (HP:0003128) | 2.08790202 |
| 79 | Progressive neurologic deterioration (HP:0002344) | 2.08719096 |
| 80 | Severe muscular hypotonia (HP:0006829) | 2.08183246 |
| 81 | Onycholysis (HP:0001806) | 2.05809120 |
| 82 | Abnormal spermatogenesis (HP:0008669) | 2.05761214 |
| 83 | Impaired platelet aggregation (HP:0003540) | 2.03479489 |
| 84 | Abnormal platelet function (HP:0011869) | 2.03479489 |
| 85 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.03139751 |
| 86 | Dysostosis multiplex (HP:0000943) | 2.02923373 |
| 87 | Abnormal autonomic nervous system physiology (HP:0012332) | 2.02470200 |
| 88 | Lipid accumulation in hepatocytes (HP:0006561) | 2.02226648 |
| 89 | Respiratory failure (HP:0002878) | 1.98617389 |
| 90 | Increased muscle lipid content (HP:0009058) | 1.97948293 |
| 91 | Acanthosis nigricans (HP:0000956) | 1.97020515 |
| 92 | Abnormal trabecular bone morphology (HP:0100671) | 1.95786227 |
| 93 | Polygenic inheritance (HP:0010982) | 1.94358137 |
| 94 | CNS demyelination (HP:0007305) | 1.93001598 |
| 95 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.91444415 |
| 96 | Abnormality of glycolipid metabolism (HP:0010969) | 1.91098610 |
| 97 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.91098610 |
| 98 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.91098610 |
| 99 | Joint stiffness (HP:0001387) | 1.90855757 |
| 100 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.90052402 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 5.72399225 |
| 2 | TESK1 | 5.38654573 |
| 3 | TESK2 | 5.04660817 |
| 4 | NME2 | 4.33207788 |
| 5 | LIMK1 | 4.21335895 |
| 6 | EPHA2 | 3.59275158 |
| 7 | LMTK2 | 3.33770053 |
| 8 | ARAF | 3.08534809 |
| 9 | PIM2 | 2.61238226 |
| 10 | BUB1 | 2.50900007 |
| 11 | MAP2K7 | 2.18014508 |
| 12 | DAPK1 | 2.09454399 |
| 13 | BCKDK | 2.02959600 |
| 14 | ERN1 | 1.84498030 |
| 15 | IRAK3 | 1.67467787 |
| 16 | PHKG1 | 1.66563170 |
| 17 | PHKG2 | 1.66563170 |
| 18 | STK10 | 1.52594243 |
| 19 | TAOK2 | 1.49822599 |
| 20 | VRK1 | 1.43799079 |
| 21 | MOS | 1.39204788 |
| 22 | ABL2 | 1.35151920 |
| 23 | MST1R | 1.33464614 |
| 24 | KDR | 1.33409471 |
| 25 | SRPK1 | 1.23753401 |
| 26 | PAK4 | 1.19640185 |
| 27 | TAF1 | 1.17427317 |
| 28 | MAP3K12 | 1.10309545 |
| 29 | CSNK1G3 | 1.09056835 |
| 30 | HIPK2 | 1.07322588 |
| 31 | MAPKAPK3 | 1.06301987 |
| 32 | STK16 | 1.04517213 |
| 33 | CSNK1A1L | 0.99449725 |
| 34 | MAP3K11 | 0.98874513 |
| 35 | ERBB4 | 0.98721866 |
| 36 | NEK1 | 0.97761499 |
| 37 | GRK5 | 0.90939099 |
| 38 | BRSK1 | 0.90344771 |
| 39 | EPHB2 | 0.90334479 |
| 40 | MST4 | 0.88615473 |
| 41 | PTK2 | 0.88111907 |
| 42 | CDK8 | 0.86630750 |
| 43 | BRAF | 0.85561213 |
| 44 | AURKA | 0.85503506 |
| 45 | TBK1 | 0.84256876 |
| 46 | PTK2B | 0.82943074 |
| 47 | DAPK2 | 0.77481175 |
| 48 | ILK | 0.74935431 |
| 49 | CSNK1G2 | 0.74569901 |
| 50 | CSNK1G1 | 0.73602616 |
| 51 | CCNB1 | 0.72842479 |
| 52 | DAPK3 | 0.71663176 |
| 53 | MYLK | 0.70842481 |
| 54 | SCYL2 | 0.69665936 |
| 55 | PAK1 | 0.68887299 |
| 56 | SMG1 | 0.67718997 |
| 57 | TGFBR2 | 0.65031115 |
| 58 | GRK7 | 0.64433379 |
| 59 | MAP3K3 | 0.61951227 |
| 60 | NUAK1 | 0.60951192 |
| 61 | CDK7 | 0.58172757 |
| 62 | LRRK2 | 0.56165532 |
| 63 | EPHB1 | 0.53238751 |
| 64 | RAF1 | 0.51617983 |
| 65 | PRPF4B | 0.50699708 |
| 66 | PRKCI | 0.49449137 |
| 67 | BMX | 0.49008871 |
| 68 | CDK14 | 0.47207685 |
| 69 | CDC7 | 0.45054868 |
| 70 | PDK2 | 0.44559534 |
| 71 | CDK19 | 0.43621820 |
| 72 | CDK15 | 0.39839753 |
| 73 | CDK18 | 0.39210129 |
| 74 | CDK11A | 0.38741494 |
| 75 | EIF2AK2 | 0.38590653 |
| 76 | PLK1 | 0.37166481 |
| 77 | MET | 0.36814371 |
| 78 | CAMKK2 | 0.35124944 |
| 79 | AURKB | 0.34537169 |
| 80 | IKBKE | 0.33457325 |
| 81 | ADRBK1 | 0.32498197 |
| 82 | MAPKAPK2 | 0.32154897 |
| 83 | PLK3 | 0.28277058 |
| 84 | GSK3A | 0.27333262 |
| 85 | EPHA4 | 0.25698406 |
| 86 | RPS6KA5 | 0.23616633 |
| 87 | CAMK2G | 0.22718664 |
| 88 | FER | 0.21308567 |
| 89 | MAPKAPK5 | 0.20990583 |
| 90 | MAP3K8 | 0.20416516 |
| 91 | TLK1 | 0.18722350 |
| 92 | PTK6 | 0.14002927 |
| 93 | PRKD1 | 0.13962331 |
| 94 | MAP3K5 | 0.12933852 |
| 95 | MAP3K1 | 0.12564117 |
| 96 | MAP4K2 | 0.11957764 |
| 97 | * CSNK2A2 | 0.11247483 |
| 98 | PBK | 0.09665306 |
| 99 | CSNK2A1 | 0.09258164 |
| 100 | CSNK1A1 | 0.08670141 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 5.17132393 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.68451528 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.12477134 |
| 4 | Base excision repair_Homo sapiens_hsa03410 | 2.66802243 |
| 5 | Parkinsons disease_Homo sapiens_hsa05012 | 2.63668929 |
| 6 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.62453928 |
| 7 | Mismatch repair_Homo sapiens_hsa03430 | 2.62116849 |
| 8 | RNA polymerase_Homo sapiens_hsa03020 | 2.51184328 |
| 9 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.51072531 |
| 10 | Sulfur relay system_Homo sapiens_hsa04122 | 2.33425954 |
| 11 | Huntingtons disease_Homo sapiens_hsa05016 | 2.30741988 |
| 12 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.25794244 |
| 13 | Alzheimers disease_Homo sapiens_hsa05010 | 2.18786613 |
| 14 | Galactose metabolism_Homo sapiens_hsa00052 | 2.06811066 |
| 15 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.04969826 |
| 16 | Glutathione metabolism_Homo sapiens_hsa00480 | 2.03644685 |
| 17 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.92379138 |
| 18 | Ribosome_Homo sapiens_hsa03010 | 1.87926767 |
| 19 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.87393565 |
| 20 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.86649264 |
| 21 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.86515319 |
| 22 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.86313204 |
| 23 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.74486164 |
| 24 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.73468277 |
| 25 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.71037302 |
| 26 | * Salivary secretion_Homo sapiens_hsa04970 | 1.63492124 |
| 27 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.56953056 |
| 28 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.55715742 |
| 29 | Homologous recombination_Homo sapiens_hsa03440 | 1.49427109 |
| 30 | Carbon metabolism_Homo sapiens_hsa01200 | 1.43189144 |
| 31 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.40986060 |
| 32 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.37168540 |
| 33 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.36581598 |
| 34 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.35557266 |
| 35 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.35515617 |
| 36 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.27463571 |
| 37 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.24935327 |
| 38 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.23891564 |
| 39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.23606421 |
| 40 | Purine metabolism_Homo sapiens_hsa00230 | 1.05813720 |
| 41 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.04080079 |
| 42 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.97360236 |
| 43 | Other glycan degradation_Homo sapiens_hsa00511 | 0.93957882 |
| 44 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.92767946 |
| 45 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.91857748 |
| 46 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.88499453 |
| 47 | Shigellosis_Homo sapiens_hsa05131 | 0.85256469 |
| 48 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.83914317 |
| 49 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.81429795 |
| 50 | Lysosome_Homo sapiens_hsa04142 | 0.80954974 |
| 51 | Metabolic pathways_Homo sapiens_hsa01100 | 0.75974100 |
| 52 | Apoptosis_Homo sapiens_hsa04210 | 0.74390178 |
| 53 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.73804357 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.70669557 |
| 55 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.66430792 |
| 56 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.64086756 |
| 57 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.61442537 |
| 58 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.59913950 |
| 59 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.59740853 |
| 60 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.56600545 |
| 61 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.53730061 |
| 62 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.50526420 |
| 63 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.50319406 |
| 64 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.50005143 |
| 65 | Endocytosis_Homo sapiens_hsa04144 | 0.49839919 |
| 66 | Bladder cancer_Homo sapiens_hsa05219 | 0.49476703 |
| 67 | Peroxisome_Homo sapiens_hsa04146 | 0.49358665 |
| 68 | Viral myocarditis_Homo sapiens_hsa05416 | 0.48608920 |
| 69 | Spliceosome_Homo sapiens_hsa03040 | 0.47902910 |
| 70 | Cell cycle_Homo sapiens_hsa04110 | 0.47022642 |
| 71 | Salmonella infection_Homo sapiens_hsa05132 | 0.45283379 |
| 72 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.44628344 |
| 73 | Mineral absorption_Homo sapiens_hsa04978 | 0.44068602 |
| 74 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.43003141 |
| 75 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.41271099 |
| 76 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.40751304 |
| 77 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.39611074 |
| 78 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.37683532 |
| 79 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.37266811 |
| 80 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.37167916 |
| 81 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.33629019 |
| 82 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.32079475 |
| 83 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.30139284 |
| 84 | RNA transport_Homo sapiens_hsa03013 | 0.29607776 |
| 85 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.29566527 |
| 86 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.27848465 |
| 87 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.26083948 |
| 88 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.25338938 |
| 89 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.24234151 |
| 90 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.22529571 |
| 91 | Protein export_Homo sapiens_hsa03060 | 0.20336901 |
| 92 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.20222472 |
| 93 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.18308472 |
| 94 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.18146300 |
| 95 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.15324272 |
| 96 | Phagosome_Homo sapiens_hsa04145 | 0.14777834 |
| 97 | Pertussis_Homo sapiens_hsa05133 | 0.14478537 |
| 98 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.14393816 |
| 99 | Legionellosis_Homo sapiens_hsa05134 | 0.14252822 |
| 100 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.12459573 |

